Genetic analysis of the antibody response to AAV2 and factor IX
Open Access
- 30 June 2005
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 11 (6), 866-874
- https://doi.org/10.1016/j.ymthe.2005.02.014
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Mapping of genes that control the antibody response to human factor IX in miceBlood, 2005
- Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in miceBlood, 2004
- Rapid Uncoating of Vector Genomes Is the Key toEfficient Liver Transduction with Pseudotyped Adeno-Associated VirusVectorsJournal of Virology, 2004
- Identification of multiple genetic loci that regulate adenovirus gene therapyGene Therapy, 2003
- Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapyBlood, 2003
- Improved Hepatic Gene Transfer by Using an Adeno-Associated Virus Serotype 5 VectorJournal of Virology, 2002
- Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene TherapyHuman Gene Therapy, 2002
- Risk and Prevention of Anti-factor IX Formation in AAV-Mediated Gene Transfer in the Context of a Large Deletion of F9Molecular Therapy, 2001
- Genetic dissection of complex traits: guidelines for interpreting and reporting linkage resultsNature Genetics, 1995
- Chromosomal location of structural genes encoding murine immunoglobulin lambda light chains. Genetics of murine lambda light chains.The Journal of Experimental Medicine, 1981